{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:41:32Z","timestamp":1792687292479,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":21,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bone.2026.118142","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:21:57Z","timestamp":1792624917000},"page":"118142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond antifracture efficacy: Osteoanabolic versus antiresorptive therapy for chronic pain after osteoporotic vertebral fractures. A systematic review and meta-analysis"],"prefix":"10.1016","author":[{"given":"Lorenzo","family":"Massei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Chiaramonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Atzori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Graziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Tarantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Ceci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2026.118142_bb0005","doi-asserted-by":"crossref","DOI":"10.1051\/sicotj\/2025035","article-title":"Osteoporotic vertebral fractures: an update","author":"Daskalakis","year":"2025","journal-title":"SICOT J."},{"key":"10.1016\/j.bone.2026.118142_bb0010","first-page":"592","article-title":"Identifying osteoporotic vertebral fracture","volume":"5","author":"Griffith","year":"2015","journal-title":"Quant. Imaging Med. Surg."},{"key":"10.1016\/j.bone.2026.118142_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/jimaging10100244","article-title":"Radiological diagnosis and advances in imaging of vertebral compression fractures","volume":"10","author":"Miao","year":"2024","journal-title":"J. Imaging"},{"key":"10.1016\/j.bone.2026.118142_bb0020","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3174\/ajnr.A2817","article-title":"Natural history of pain in patients with conservatively treated osteoporotic vertebral compression fractures: results from VERTOS II","volume":"33","author":"Venmans","year":"2012","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.bone.2026.118142_bb0025","doi-asserted-by":"crossref","DOI":"10.1186\/s12877-019-1268-y","article-title":"Associations between health-related quality of life, physical function and pain in older women with osteoporosis and vertebral fracture","volume":"19","author":"Stanghelle","year":"2019","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.bone.2026.118142_bb0030","article-title":"Availability of observational pain assessment tools in hospitalized patients with osteoporotic vertebral fractures","volume":"60","author":"Yoshimi","year":"2024","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.bone.2026.118142_bb0035","doi-asserted-by":"crossref","first-page":"934","DOI":"10.31616\/asj.2022.0441","article-title":"Management of osteoporotic vertebral fracture: review update 2022","volume":"16","author":"Jang","year":"2022","journal-title":"Asian Spine J."},{"key":"10.1016\/j.bone.2026.118142_bb0040","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1210\/jc.2019-00221","article-title":"Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society* clinical practice guideline","volume":"104","author":"Eastell","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2026.118142_bb0045","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa048","article-title":"Pharmacological management of osteoporosis in postmenopausal women: an endocrine society guideline update","volume":"105","author":"Shoback","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2026.118142_bb0050","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0140-6736(17)32137-2","article-title":"Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial","volume":"391","author":"Kendler","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2026.118142_bb0055","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2026.118142_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11061566","article-title":"Factors contributing to residual low back pain after osteoporotic vertebral fractures","volume":"11","author":"Inose","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bone.2026.118142_bb0065","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1007\/s00586-024-08426-z","article-title":"Incidence and prognostic factors of residual back pain in patients treated for osteoporotic vertebral compression fractures: a systematic review and meta-analysis","volume":"33","author":"Yang","year":"2024","journal-title":"Eur. Spine J."},{"key":"10.1016\/j.bone.2026.118142_bb0070","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00774-014-0646-y","article-title":"The effect of teriparatide to alleviate pain and to prevent vertebral collapse after fresh osteoporotic vertebral fracture","volume":"34","author":"Tsuchie","year":"2016","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bone.2026.118142_bb0075","doi-asserted-by":"crossref","DOI":"10.1186\/s12891-017-1509-1","article-title":"Effect of teriparatide (rh-PTH 1-34) versus bisphosphonate on the healing of osteoporotic vertebral compression fracture: a retrospective comparative study","volume":"18","author":"Iwata","year":"2017","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.bone.2026.118142_bb0080","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.bone.2026.118142_bb0085","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6947-7-16","article-title":"Utilization of the PICO framework to improve searching PubMed for clinical questions","volume":"7","author":"Schardt","year":"2007","journal-title":"BMC Med. Inform. Decis. Mak."},{"key":"10.1016\/j.bone.2026.118142_bb0090","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s00198-011-1856-y","article-title":"The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures","volume":"23","author":"Hadji","year":"2012","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2026.118142_bb0095","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00774-019-01023-x","article-title":"Comparison of once-weekly teriparatide and alendronate against new osteoporotic vertebral fractures at week 12","volume":"38","author":"Ikeda","year":"2020","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bone.2026.118142_bb0100","first-page":"442","article-title":"Teriparatide vs. alendronate as a treatment for osteoporosis: changes in biochemical markers of bone turnover, BMD and quality of life","volume":"11","author":"Panico","year":"2011","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.bone.2026.118142_bb0105","article-title":"The efficacy of osteoporotic treatment in patients with new spinal vertebral compression fracture pain, ADL, QOL, bone metabolism and fracture-healing - in comparison with weekly teriparatide with bisphosphonate","volume":"11","author":"Shigenobu","year":"2019","journal-title":"Bone Rep."},{"key":"10.1016\/j.bone.2026.118142_bb0110","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1007\/s00198-016-3651-2","article-title":"Aggravation of spinal cord compromise following new osteoporotic vertebral compression fracture prevented by teriparatide in patients with surgical contraindications","volume":"27","author":"Zhao","year":"2016","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2026.118142_bb0115","first-page":"200","article-title":"Safety and effectiveness of teriparatide vs alendronate in postmenopausal osteoporosis: a prospective non randomized clinical study","volume":"13","author":"Caggiari","year":"2016","journal-title":"Clin. Cases Miner. Bone Metab."},{"key":"10.1016\/j.bone.2026.118142_bb0120","doi-asserted-by":"crossref","DOI":"10.1093\/jbmrpl\/ziae137","article-title":"Romosozumab versus bisphosphonates for preventing subsequent vertebral fractures after balloon kyphoplasty: comparison using data from two prospective multicenter studies","volume":"9","author":"Inose","year":"2024","journal-title":"JBMR Plus"},{"key":"10.1016\/j.bone.2026.118142_bb0125","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00198-024-07025-4","article-title":"Comparison of radiological and functional outcomes of conservative treatment with teriparatide and denosumab in thoracolumbar osteoporotic vertebral fracture","volume":"35","author":"Jeon","year":"2024","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2026.118142_bb0130","article-title":"Impact of teriparatide and denosumab on clinical and radiographic outcomes in osteoporotic vertebral compression fractures","volume":"60","author":"Kwon","year":"2024","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.bone.2026.118142_bb0135","article-title":"Comparison of osteoanabolic agents (teriparatide and romosozumab) with bisphosphonates in prevention of subsequent vertebral fractures in patients treated for osteoporotic vertebral fracture for 12 months: an observational cohort study","volume":"21","author":"Maruo","year":"2024","journal-title":"Bone Rep."},{"key":"10.1016\/j.bone.2026.118142_bb0140","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.31616\/asj.2023.0109","article-title":"Is teriparatide superior in treating osteoporotic vertebral compression fractures in comparison to bisphosphonates treatment alone: a 2-year retrospective analysis","volume":"17","author":"Nair","year":"2023","journal-title":"Asian Spine J."},{"key":"10.1016\/j.bone.2026.118142_bb0145","doi-asserted-by":"crossref","DOI":"10.1007\/s11657-024-01374-7","article-title":"Comparative analysis of anti-osteoporosis medications in preventing vertebral body fractures after balloon kyphoplasty","volume":"19","author":"Ueno","year":"2024","journal-title":"Arch. Osteoporos."},{"key":"10.1016\/j.bone.2026.118142_bb0150","doi-asserted-by":"crossref","DOI":"10.1186\/s12891-025-09256-w","article-title":"Sequential anti-osteoporotic therapy with teriparatide and alendronate optimizes outcomes of percutaneous vertebroplasty in acute osteoporotic vertebral fractures: a 12-month prospective cohort study","volume":"26","author":"Xie","year":"2025","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.bone.2026.118142_bb0155","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00586-009-1041-6","article-title":"Factors affecting neurological deficits and intractable back pain in patients with insufficient bone union following osteoporotic vertebral fracture","volume":"18","author":"Hoshino","year":"2009","journal-title":"Eur. Spine J."},{"key":"10.1016\/j.bone.2026.118142_bb0160","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jos.2016.12.002","article-title":"Relationship between clinical symptoms of osteoporotic vertebral fracture with intravertebral cleft and radiographic findings","volume":"22","author":"Nakamae","year":"2017","journal-title":"J. Orthop. Sci."},{"key":"10.1016\/j.bone.2026.118142_bb0165","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1097\/01.brs.0000247802.91724.7e","article-title":"Changes in vertebral wedging rate between supine and standing position and its association with back pain: a prospective study in patients with osteoporotic vertebral compression fractures","volume":"31","author":"Toyone","year":"2006","journal-title":"Spine"},{"key":"10.1016\/j.bone.2026.118142_bb0170","doi-asserted-by":"crossref","DOI":"10.2147\/JPR.S567567","article-title":"Molecular mechanisms and therapeutic targets for pain following osteoporotic vertebral fractures","volume":"19","author":"Zhou","year":"2026","journal-title":"J. Pain Res."},{"key":"10.1016\/j.bone.2026.118142_bb0175","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ejp.1662","article-title":"Physiologic osteoclasts are not sufficient to induce skeletal pain in mice","volume":"25","author":"de Clauser","year":"2021","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.bone.2026.118142_bb0180","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s11914-020-00624-0","article-title":"The effects of calcitonin gene-related peptide on bone homeostasis and regeneration","volume":"18","author":"Xu","year":"2020","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.bone.2026.118142_bb0185","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1097\/j.pain.0000000000002543","article-title":"Antibody-induced pain-like behavior and bone erosion: links to subclinical inflammation, osteoclast activity, and acid-sensing ion channel 3-dependent sensitization","volume":"163","author":"Jurczak","year":"2022","journal-title":"Pain"},{"key":"10.1016\/j.bone.2026.118142_bb0190","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1097\/j.pain.0000000000001939","article-title":"The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises","volume":"161","author":"Raja","year":"2020","journal-title":"Pain"},{"key":"10.1016\/j.bone.2026.118142_bb0195","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/BRS.0b013e31815e3a10","article-title":"Interpreting change scores for pain and functional status in low back pain: towards international consensus regarding minimal important change","volume":"33","author":"Ostelo","year":"2008","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.bone.2026.118142_bb0200","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1097\/j.pain.0000000000001952","article-title":"Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations","volume":"161","author":"Smith","year":"2020","journal-title":"Pain"},{"key":"10.1016\/j.bone.2026.118142_bb0205","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s40259-021-00504-8","article-title":"Nerve growth factor (NGF) inhibitors and related agents for chronic musculoskeletal pain: a comprehensive review","volume":"35","author":"Oo","year":"2021","journal-title":"BioDrugs"},{"key":"10.1016\/j.bone.2026.118142_bb0210","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/bph.15605","article-title":"Beyond CGRP: the calcitonin peptide family as targets for migraine and pain","volume":"179","author":"Rees","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bone.2026.118142_bb0215","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.sjbs.2021.02.026","article-title":"Neurokinin-1-tachykinin receptor agonist promotes diabetic fracture healing in rats with type 1 diabetes via modulation of Wnt\/\u03b2-catenin signalling axis","volume":"28","author":"Wang","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.bone.2026.118142_bb0220","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11914-023-00846-y","article-title":"Cracking the code: the role of peripheral nervous system signaling in fracture repair","volume":"22","author":"Morris","year":"2024","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.bone.2026.118142_bb0225","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11914-023-00844-0","article-title":"Role of the neurologic system in fracture healing: an extensive review","volume":"22","author":"Parker","year":"2024","journal-title":"Curr. Osteoporos. Rep."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328226003686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328226003686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:11:32Z","timestamp":1792685492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328226003686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":45,"alternative-id":["S8756328226003686"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2026.118142","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond antifracture efficacy: Osteoanabolic versus antiresorptive therapy for chronic pain after osteoporotic vertebral fractures. A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2026.118142","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118142"}}